Michèle Leunen

Michèle Leunen is a Clinical Professor at the Vrije Universiteit Brussel, affiliated with the Faculty of Medicine and Pharmacy and the Centre for Reproductive Medicine - Gynaecology. Her expertise spans gynaecology, reproductive medicine, oncology, and endocrinology. She actively contributes to clinical research, particularly in hormonal therapy for menopause and contraception-related thromboembolism risks.

Education & Professional Background: While specific academic qualifications are not detailed, her roles as a clinical professor and physician at UZ Brussel indicate advanced medical training. She is also an external employee of the institution, reflecting her dual role in clinical practice and academic research.

Research Interests: Her work focuses on endometrial stromal tumors, vulvar lesions, and hormonal therapies. She frequently addresses topics like menopause management, contraceptive safety, and gynaecological oncology. Her research integrates clinical practice with translational medicine, aiming to improve patient outcomes in reproductive health and oncology.

Activities & Media: Dr. Leunen is highly active in academic and public engagement. She has participated in over 300 activities, including conferences (e.g., PGO 2026, IMS 2025), workshops, and consultations. She frequently provides expert commentary on media platforms, addressing issues like vaginal dryness, premenstrual dysphoric disorder (PMDD), and hormonal replacement therapy in menopause. Recent media contributions include discussions on managing menopausal symptoms and promoting hormone therapy awareness.

Labs & Collaborations: Her primary affiliation is with the Centre for Reproductive Medicine, where she collaborates on projects involving reproductive endocrinology, gynaecological oncology, and clinical guidelines for contraception and menopausal care. She also contributes to multidisciplinary teams addressing public health challenges in women’s healthcare.